193 related articles for article (PubMed ID: 20012075)
1. Treatment of Laugier-Hunziker syndrome with the Q-switched alexandrite laser in 22 Chinese patients.
Zuo YG; Ma DL; Jin HZ; Liu YH; Wang HW; Sun QN
Arch Dermatol Res; 2010 Mar; 302(2):125-30. PubMed ID: 20012075
[TBL] [Abstract][Full Text] [Related]
2. A case of recurrent pigmented macules in Laugier-Hunziker syndrome treated using a Q-switched Nd-YAG laser.
Choi ME; Jung CJ; Lee WJ; Won CH; Chang SE; Lee MW; Choi JH; Paik SH
J Cosmet Laser Ther; 2019; 21(7-8):395-397. PubMed ID: 31619092
[TBL] [Abstract][Full Text] [Related]
3. Q-switched alexandrite laser therapy for pigmentation of the lips owing to Laugier-Hunziker syndrome.
Ozawa T; Fujiwara M; Harada T; Muraoka M; Ishii M
Dermatol Surg; 2005 Jun; 31(6):709-12. PubMed ID: 15996427
[TBL] [Abstract][Full Text] [Related]
4. Laugier-Hunziker syndrome: case report and treatment with the Q-switched Nd-Yag laser.
Ferreira MJ; Ferreira AM; Soares AP; Rodrigues JC
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):171-3. PubMed ID: 10343950
[TBL] [Abstract][Full Text] [Related]
5. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
6. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser.
Alster TS; Gupta SN
Dermatol Surg; 2004 Sep; 30(9):1201-4. PubMed ID: 15355359
[TBL] [Abstract][Full Text] [Related]
7. Laugier-Hunziker syndrome: A case report and review of the literature.
Rangwala S; Doherty CB; Katta R
Dermatol Online J; 2010 Dec; 16(12):9. PubMed ID: 21199635
[TBL] [Abstract][Full Text] [Related]
8. Use of 532-nm Q-switched Nd:YAG laser for smoker's gingival hyperpigmentation.
Cho SB; Lee JH; Seo W; Bang D
J Cosmet Laser Ther; 2010 Apr; 12(2):77-80. PubMed ID: 20331344
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acquired bilateral nevus of ota-like macules (Hori's nevus) with a combination of the 532 nm Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched Nd:YAG is more effective: prospective study.
Ee HL; Goh CL; Khoo LS; Chan ES; Ang P
Dermatol Surg; 2006 Jan; 32(1):34-40. PubMed ID: 16393596
[TBL] [Abstract][Full Text] [Related]
11. Laugier-Hunziker-Baran syndrome.
Yago K; Tanaka Y; Asanami S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):e20-5. PubMed ID: 18468464
[TBL] [Abstract][Full Text] [Related]
12. Treatment of congenital nevi with the Q-switched Alexandrite laser.
Kim S; Kang WH
Eur J Dermatol; 2005; 15(2):92-6. PubMed ID: 15757819
[TBL] [Abstract][Full Text] [Related]
13. Use of the Q-switched Nd:YAG laser for the treatment of pigmentary disorders in Egyptians.
Salem A; El Harras M; Ramadan A; Gamil H; Rahman AA; El-Said K
J Cosmet Laser Ther; 2010 Apr; 12(2):92-100. PubMed ID: 20331347
[TBL] [Abstract][Full Text] [Related]
14. Dermoscopic findings and histological correlation of the acral volar pigmented maculae in Laugier-Hunziker syndrome.
Sendagorta E; Feito M; Ramírez P; Gonzalez-Beato M; Saida T; Pizarro A
J Dermatol; 2010 Nov; 37(11):980-4. PubMed ID: 21039787
[TBL] [Abstract][Full Text] [Related]
15. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: a randomized, physician-blinded, split-face comparative trial.
Wang CC; Sue YM; Yang CH; Chen CK
J Am Acad Dermatol; 2006 May; 54(5):804-10. PubMed ID: 16635661
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Ota's nevus by Q-switched alexandrite laser : therapeutic outcome in relation to clinical and histopathological findings.
Kang W; Lee E; Choi GS
Eur J Dermatol; 1999 Dec; 9(8):639-43. PubMed ID: 10586133
[TBL] [Abstract][Full Text] [Related]
17. Dermoscopic findings in Laugier-Hunziker syndrome.
Gencoglan G; Gerceker-Turk B; Kilinc-Karaarslan I; Akalin T; Ozdemir F
Arch Dermatol; 2007 May; 143(5):631-3. PubMed ID: 17515514
[TBL] [Abstract][Full Text] [Related]
18. Laugier and Hunziker pigmentation: a lentiginous proliferation of melanocytes.
Moore RT; Chae KA; Rhodes AR
J Am Acad Dermatol; 2004 May; 50(5 Suppl):S70-4. PubMed ID: 15097932
[TBL] [Abstract][Full Text] [Related]
19. Lentigo maligna--outcomes of treatment with Q-switched Nd:YAG and alexandrite lasers.
Madan V; August PJ
Dermatol Surg; 2009 Apr; 35(4):607-11; discussion 611-2. PubMed ID: 19309345
[TBL] [Abstract][Full Text] [Related]
20. Long-pulsed neodymium:yttrium-aluminum-garnet laser treatment for hypertrophic port-wine stains on the lips.
Kono T; Frederick Groff W; Chan HH; Sakurai H; Yamaki T
J Cosmet Laser Ther; 2009 Mar; 11(1):11-3. PubMed ID: 18830868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
